Bessemer Group Inc. Lowers Stock Holdings in GE HealthCare Technologies Inc. $GEHC

Bessemer Group Inc. trimmed its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 11.5% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 5,905 shares of the company’s stock after selling 766 shares during the period. Bessemer Group Inc.’s holdings in GE HealthCare Technologies were worth $437,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in GEHC. Mutual Advisors LLC lifted its holdings in shares of GE HealthCare Technologies by 114.1% during the first quarter. Mutual Advisors LLC now owns 6,390 shares of the company’s stock valued at $516,000 after purchasing an additional 3,406 shares during the last quarter. Principal Financial Group Inc. lifted its holdings in shares of GE HealthCare Technologies by 2.4% during the first quarter. Principal Financial Group Inc. now owns 950,055 shares of the company’s stock valued at $76,679,000 after purchasing an additional 21,962 shares during the last quarter. Calamos Advisors LLC lifted its holdings in shares of GE HealthCare Technologies by 0.7% during the first quarter. Calamos Advisors LLC now owns 108,774 shares of the company’s stock valued at $8,779,000 after purchasing an additional 711 shares during the last quarter. Silver Oak Securities Incorporated purchased a new position in shares of GE HealthCare Technologies during the first quarter valued at approximately $243,000. Finally, OneDigital Investment Advisors LLC lifted its holdings in shares of GE HealthCare Technologies by 32.1% during the first quarter. OneDigital Investment Advisors LLC now owns 38,409 shares of the company’s stock valued at $3,100,000 after purchasing an additional 9,328 shares during the last quarter. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

GE HealthCare Technologies Trading Down 0.1%

NASDAQ:GEHC opened at $74.95 on Monday. The company has a current ratio of 1.18, a quick ratio of 0.95 and a debt-to-equity ratio of 0.83. GE HealthCare Technologies Inc. has a 12 month low of $57.65 and a 12 month high of $94.80. The company has a market cap of $34.14 billion, a PE ratio of 15.49, a price-to-earnings-growth ratio of 2.82 and a beta of 1.13. The company has a 50 day simple moving average of $75.09 and a two-hundred day simple moving average of $73.14.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, October 29th. The company reported $1.07 EPS for the quarter, topping analysts’ consensus estimates of $1.05 by $0.02. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. The business had revenue of $5.14 billion during the quarter, compared to the consensus estimate of $5.07 billion. During the same quarter in the previous year, the firm posted $1.14 EPS. The firm’s revenue was up 5.8% on a year-over-year basis. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. Research analysts forecast that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 24th will be given a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date of this dividend is Friday, October 24th. GE HealthCare Technologies’s payout ratio is 2.89%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the stock. Evercore ISI lifted their target price on shares of GE HealthCare Technologies from $88.00 to $92.00 and gave the company an “outperform” rating in a report on Thursday. Citigroup downgraded shares of GE HealthCare Technologies from a “buy” rating to a “neutral” rating and reduced their price target for the company from $93.00 to $83.00 in a research report on Tuesday, October 7th. BTIG Research set a $87.00 price target on shares of GE HealthCare Technologies in a research report on Wednesday. Zacks Research downgraded shares of GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 29th. Finally, Barclays assumed coverage on shares of GE HealthCare Technologies in a research report on Monday, October 13th. They set an “equal weight” rating and a $86.00 price target for the company. Six equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $86.10.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.